Drug Discovery & Device Research and Development (R&D) Services:
Committed to Quality of Life through Novel Drugs, Biologics and Medical Devices
Toxikon offers specialty and custom research and testing services in support of drug discovery, development, and post marketing support. These include early stage drug efficacy and IND enabling studies, method development and validation, synthesis and formulation, complex study designs and execution, and full support services including anatomical and clinical pathology. Working closely with our clients, we are committed to providing customized research services to meet all of their scientific and regulatory objectives.
Toxikon Research Programs Available for Partnering
While we have built a strong reputation based on our rigorous study designs for regulatory submissions, we are equally committed to providing reliable preclinical development capabilities to support early discovery of novel therapies for the treatment of new and existing diseases. Several of our research programs are available for partnering, including:
Antivirals: The discovery of novel nucleoside- and non-nucleoside-based antivirals with robust in vitro profiles for the treatment of HIV and the Hepatitis C virus.
Kinase Inhibitors: An oncology research program focused on discovering kinase inhibitors for the effective treatment of cancer.